APO RESEARCH · REPORT
Sanger Sequencing Service
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
Product & engineering
Understand the product.
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
Selected research
Market Structure
Global Sanger Sequencing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
Global Sanger Sequencing Service key players include Eurofins, Thermofisher, Genewiz, Nucleics, SciGenom Labs, etc. Global top five manufacturers hold a share about 70%. United States is the largest market, with a share about 25%, followed by Europe and China, both with a share about 20 percent. In terms of product, PCR amplicons is the largest segment, with a share about 60%. And in terms of application, the largest application is Institutions, followed by Bioscience Companies, Hospitals.
Report Includes
Read the full market overview
This report provides an overview of the global Sanger Sequencing Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sanger Sequencing Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sanger Sequencing Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Sanger Sequencing Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Sanger Sequencing Service Segment by Company
Source BioScience
GenScript
Thermofisher
Nucleics
GenHunter Corporation
LGC Limited
SciGenom Labs
Fasteris SA
CeMIA SA
Microsynth AG
QuintaraBio
Eurofins
Genewiz
Sanger Sequencing Service Segment by Type
Plasmid DNA
PCR Amplicons
Others
Sanger Sequencing Service Segment by Application
Bioscience Companies
Hospitals
Institutions
Sanger Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sanger Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sanger Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sanger Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Sanger Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sanger Sequencing Service industry.
Chapter 3: Detailed analysis of Sanger Sequencing Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sanger Sequencing Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plasmid DNA
- PCR Amplicons
- Others
Applications
- Bioscience Companies
- Hospitals
- Institutions
Companies covered
- Source BioScience
- GenScript
- Thermofisher
- Nucleics
- GenHunter Corporation
- LGC Limited
- SciGenom Labs
- Fasteris SA
- CeMIA SA
- Microsynth AG
- QuintaraBio
- Eurofins
- Genewiz
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Sanger Sequencing Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Plasmid DNA
- 1.2.3 PCR Amplicons
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Sanger Sequencing Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Bioscience Companies
- 1.3.3 Hospitals
- 1.3.4 Institutions
- 1.4 Global Market Growth Prospects
- 1.5 Global Sanger Sequencing Service Growth Trends by Region
- 1.5.1 Global Sanger Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Sanger Sequencing Service Market Size by Region (2021-2026)
- 1.5.3 Sanger Sequencing Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Sanger Sequencing Service Market Dynamics
- 2.1 Sanger Sequencing Service Industry Trends
- 2.2 Sanger Sequencing Service Industry Drivers
- 2.3 Sanger Sequencing Service Industry Opportunities and Challenges
- 2.4 Sanger Sequencing Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Sanger Sequencing Service Revenue by Company (2021-2026)
- 3.2 Global Sanger Sequencing Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Sanger Sequencing Service Key Company Head office and Area Served
- 3.4 Global Sanger Sequencing Service Company, Product Type & Application
- 3.5 Global Sanger Sequencing Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Sanger Sequencing Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Sanger Sequencing Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Sanger Sequencing Service Tier 1, Tier 2, and Tier 3
4 Sanger Sequencing Service Market by Type
- 4.1 Global Sanger Sequencing Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Sanger Sequencing Service Market Size by Type (2021-2032)
- 4.3 Global Sanger Sequencing Service Market Size Share by Type (2021-2032)
5 Sanger Sequencing Service Market by Application
- 5.1 Global Sanger Sequencing Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Sanger Sequencing Service Market Size by Application (2021-2032)
- 5.3 Global Sanger Sequencing Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Source BioScience
- 6.1.1 Source BioScience Company Information
- 6.1.2 Source BioScience Business Overview
- 6.1.3 Source BioScience Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Source BioScience Sanger Sequencing Service Product Portfolio
- 6.1.5 Source BioScience Recent Developments
- 6.2 GenScript
- 6.2.1 GenScript Company Information
- 6.2.2 GenScript Business Overview
- 6.2.3 GenScript Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 GenScript Sanger Sequencing Service Product Portfolio
- 6.2.5 GenScript Recent Developments
- 6.3 Thermofisher
- 6.3.1 Thermofisher Company Information
- 6.3.2 Thermofisher Business Overview
- 6.3.3 Thermofisher Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Thermofisher Sanger Sequencing Service Product Portfolio
- 6.3.5 Thermofisher Recent Developments
- 6.4 Nucleics
- 6.4.1 Nucleics Company Information
- 6.4.2 Nucleics Business Overview
- 6.4.3 Nucleics Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Nucleics Sanger Sequencing Service Product Portfolio
- 6.4.5 Nucleics Recent Developments
- 6.5 GenHunter Corporation
- 6.5.1 GenHunter Corporation Company Information
- 6.5.2 GenHunter Corporation Business Overview
- 6.5.3 GenHunter Corporation Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 GenHunter Corporation Sanger Sequencing Service Product Portfolio
- 6.5.5 GenHunter Corporation Recent Developments
- 6.6 LGC Limited
- 6.6.1 LGC Limited Company Information
- 6.6.2 LGC Limited Business Overview
- 6.6.3 LGC Limited Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 LGC Limited Sanger Sequencing Service Product Portfolio
- 6.6.5 LGC Limited Recent Developments
- 6.7 SciGenom Labs
- 6.7.1 SciGenom Labs Company Information
- 6.7.2 SciGenom Labs Business Overview
- 6.7.3 SciGenom Labs Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 SciGenom Labs Sanger Sequencing Service Product Portfolio
- 6.7.5 SciGenom Labs Recent Developments
- 6.8 Fasteris SA
- 6.8.1 Fasteris SA Company Information
- 6.8.2 Fasteris SA Business Overview
- 6.8.3 Fasteris SA Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Fasteris SA Sanger Sequencing Service Product Portfolio
- 6.8.5 Fasteris SA Recent Developments
- 6.9 CeMIA SA
- 6.9.1 CeMIA SA Company Information
- 6.9.2 CeMIA SA Business Overview
- 6.9.3 CeMIA SA Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 CeMIA SA Sanger Sequencing Service Product Portfolio
- 6.9.5 CeMIA SA Recent Developments
- 6.10 Microsynth AG
- 6.10.1 Microsynth AG Company Information
- 6.10.2 Microsynth AG Business Overview
- 6.10.3 Microsynth AG Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Microsynth AG Sanger Sequencing Service Product Portfolio
- 6.10.5 Microsynth AG Recent Developments
- 6.11 QuintaraBio
- 6.11.1 QuintaraBio Company Information
- 6.11.2 QuintaraBio Business Overview
- 6.11.3 QuintaraBio Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 QuintaraBio Sanger Sequencing Service Product Portfolio
- 6.11.5 QuintaraBio Recent Developments
- 6.12 Eurofins
- 6.12.1 Eurofins Company Information
- 6.12.2 Eurofins Business Overview
- 6.12.3 Eurofins Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Eurofins Sanger Sequencing Service Product Portfolio
- 6.12.5 Eurofins Recent Developments
- 6.13 Genewiz
- 6.13.1 Genewiz Company Information
- 6.13.2 Genewiz Business Overview
- 6.13.3 Genewiz Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Genewiz Sanger Sequencing Service Product Portfolio
- 6.13.5 Genewiz Recent Developments
7 North America
- 7.1 North America Sanger Sequencing Service Market Size (2021-2032)
- 7.2 North America Sanger Sequencing Service Market Size by Type
- 7.2.1 North America Sanger Sequencing Service Market Size by Type (2021-2026)
- 7.2.2 North America Sanger Sequencing Service Market Size by Type (2027-2032)
- 7.2.3 North America Sanger Sequencing Service Market Share by Type (2021-2032)
- 7.3 North America Sanger Sequencing Service Market Size by Application
- 7.3.1 North America Sanger Sequencing Service Market Size by Application (2021-2026)
- 7.3.2 North America Sanger Sequencing Service Market Size by Application (2027-2032)
- 7.3.3 North America Sanger Sequencing Service Market Share by Application (2021-2032)
- 7.4 North America Sanger Sequencing Service Market Size by Country
- 7.4.1 North America Sanger Sequencing Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Sanger Sequencing Service Market Size by Country (2021-2026)
- 7.4.3 North America Sanger Sequencing Service Market Size by Country (2027-2032)
- 7.4.4 North America Sanger Sequencing Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Sanger Sequencing Service Market Size (2021-2032)
- 8.2 Europe Sanger Sequencing Service Market Size by Type
- 8.2.1 Europe Sanger Sequencing Service Market Size by Type (2021-2026)
- 8.2.2 Europe Sanger Sequencing Service Market Size by Type (2027-2032)
- 8.2.3 Europe Sanger Sequencing Service Market Share by Type (2021-2032)
- 8.3 Europe Sanger Sequencing Service Market Size by Application
- 8.3.1 Europe Sanger Sequencing Service Market Size by Application (2021-2026)
- 8.3.2 Europe Sanger Sequencing Service Market Size by Application (2027-2032)
- 8.3.3 Europe Sanger Sequencing Service Market Share by Application (2021-2032)
- 8.4 Europe Sanger Sequencing Service Market Size by Country
- 8.4.1 Europe Sanger Sequencing Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Sanger Sequencing Service Market Size by Country (2021-2026)
- 8.4.3 Europe Sanger Sequencing Service Market Size by Country (2027-2032)
- 8.4.4 Europe Sanger Sequencing Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Sanger Sequencing Service Market Size (2021-2032)
- 9.2 China Sanger Sequencing Service Market Size by Type
- 9.2.1 China Sanger Sequencing Service Market Size by Type (2021-2026)
- 9.2.2 China Sanger Sequencing Service Market Size by Type (2027-2032)
- 9.2.3 China Sanger Sequencing Service Market Share by Type (2021-2032)
- 9.3 China Sanger Sequencing Service Market Size by Application
- 9.3.1 China Sanger Sequencing Service Market Size by Application (2021-2026)
- 9.3.2 China Sanger Sequencing Service Market Size by Application (2027-2032)
- 9.3.3 China Sanger Sequencing Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Sanger Sequencing Service Market Size (2021-2032)
- 10.2 Asia Sanger Sequencing Service Market Size by Type
- 10.2.1 Asia Sanger Sequencing Service Market Size by Type (2021-2026)
- 10.2.2 Asia Sanger Sequencing Service Market Size by Type (2027-2032)
- 10.2.3 Asia Sanger Sequencing Service Market Share by Type (2021-2032)
- 10.3 Asia Sanger Sequencing Service Market Size by Application
- 10.3.1 Asia Sanger Sequencing Service Market Size by Application (2021-2026)
- 10.3.2 Asia Sanger Sequencing Service Market Size by Application (2027-2032)
- 10.3.3 Asia Sanger Sequencing Service Market Share by Application (2021-2032)
- 10.4 Asia Sanger Sequencing Service Market Size by Country
- 10.4.1 Asia Sanger Sequencing Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Sanger Sequencing Service Market Size by Country (2021-2026)
- 10.4.3 Asia Sanger Sequencing Service Market Size by Country (2027-2032)
- 10.4.4 Asia Sanger Sequencing Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Sanger Sequencing Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Sanger Sequencing Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Sanger Sequencing Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Sanger Sequencing Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Sanger Sequencing Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Sanger Sequencing Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Sanger Sequencing Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Sanger Sequencing Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Sanger Sequencing Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Sanger Sequencing Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Sanger Sequencing Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Sanger Sequencing Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Sanger Sequencing Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Sanger Sequencing Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst